This scheme promotes innovative approaches that could change our understanding, diagnosis and/or management of brain tumours. We aim to support development of novel concepts that may eventually lead to significant improvements in clinical outcome, including quality of life, for patients with brain tumours.
The awards are designed to allow exploration of theories with the potential to open new avenues of investigation. Projects funded through this scheme should be pilot awards. It is intended that the scheme will allow the generation of sufficient data to support applications for larger scale projects to national/ international funding organisations.
Funding of up to £120,000 over a 24-month period can be requested per project. The funding should be allocated to cover direct costs for staff, including salaries, consumables and publication costs. Requests for capital / infrastructure will not be considered since it is expected that this will be available at the Lead Institution as well as all partner organisations.
Grants will be awarded to the principal applicant's institution. Funding can be allocated to co-investigator institutions with agreements put in place between all partner institutions.
The 2017 scheme has closed.
1 September 2017 (5pm, London time) - Deadline for receipt of full applications
March 2018 - Biomedical SAB meeting
April 2018- Awards announced
Future funding to be confirmed in early 2018
Please read our Terms and Conditions before applying for funding.
All applications must have input from those affected by brain tumours as early as possible, preferably during scoping of the project. We strongly recommend that applicants access our Research Involvement Network (RIN) for public and patient involvement.
Relevance to brain tumours
Novelty of approach
Expertise of applicants
Feasibility of project
Potential impact on the field
The Brain Tumour Charity is a member of the Association of Medical Research Charities (AMRC) and adheres to its principles of peer review. All applications will be considered by our Biomedical Scientific Advisory Board (SAB) alongside lay representatives of people affected by brain tumours.
If you would like to discuss your application or need any information, please contact the Research Team.
E-mail: email@example.com Phone: +44 (0) 1252 418190